Insta
WHO's Emergency Use Nod For Bharat Biotech's Covaxin Delayed Till 5 October: Report
Swarajya Staff
Sep 18, 2021, 10:03 AM | Updated 10:03 AM IST
Save & read from anywhere!
Bookmark stories for easy access on any device or the Swarajya app.
The wait for the World Health Organisation (WHO)’s emergency use authorisation (EUA) for Hyderabad-based Bharat Biotech’s COVID-19 vaccine Covaxin is set to be a little longer as the global health body is said to have delayed the approval till 5 October, reports Hindustan Times.
WHO’s Strategic Advisory Group of Experts on Immunisation (SAGE) will be meeting on 5 October to decide on granting the EUA to Covaxin. It will be analysing the data from the vaccine’s first, second and third stage clinical trials.
The SAGE will also be considering post-marketing studies on safety, immunogenicity, efficacy, and effectiveness. It will also review updates on global, regional, and country-level plans for vaccine safety monitoring.
It should be noted that Covaxin is the first indigenously developed COVID-19 vaccine in India. It was developed by Dr Krishna Ella led Bharat Biotech in close collaboration with the Indian Council for Medical Research (ICMR) and the Pune-based National Institute of Virology.
Covaxin is presently the second-most administered COVID-19 vaccine in India after Covishield which is being manufactured by the Pune-based Serum Institute of India (SII). The Covishield has been developed by Swedish-British pharmaceutical major AstraZeneca and the University of Oxford.
Save & read from anywhere!
Bookmark stories for easy access on any device or the Swarajya app.
Support Swarajya's 50 Ground Reports Project & Sponsor A Story
Every general election Swarajya does a 50 ground reports project.
Aimed only at serious readers and those who appreciate the nuances of political undercurrents, the project provides a sense of India's electoral landscape. As you know, these reports are produced after considerable investment of travel, time and effort on the ground.
This time too we've kicked off the project in style and have covered over 30 constituencies already. If you're someone who appreciates such work and have enjoyed our coverage please consider sponsoring a ground report for just Rs 2999 to Rs 19,999 - it goes a long way in helping us produce more quality reportage.
You can also back this project by becoming a subscriber for as little as Rs 999 - so do click on this links and choose a plan that suits you and back us.
Click below to contribute.